Found: 11
Select item for more details and to access through your institution.
Transcription factors FOXG1 and Groucho/TLE promote glioblastoma growth.
- Published in:
- Nature Communications, 2013, v. 4, n. 12, p. 2956, doi. 10.1038/ncomms3956
- By:
- Publication type:
- Article
Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 3, p. 1, doi. 10.15252/emmm.202216104
- By:
- Publication type:
- Article
MET inhibition overcomes radiation resistance of glioblastoma stem-like cells.
- Published in:
- EMBO Molecular Medicine, 2016, v. 8, n. 5, p. 550, doi. 10.15252/emmm.201505890
- By:
- Publication type:
- Article
Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs).
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs).
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 482, n. 3, p. 463, doi. 10.1007/s00428-022-03435-z
- By:
- Publication type:
- Article
MicroRNA 483‐3p overexpression unleashes invasive growth of metastatic colorectal cancer via NDRG1 downregulation and ensuing activation of the ERBB3/AKT axis.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 7, p. 1280, doi. 10.1002/1878-0261.13408
- By:
- Publication type:
- Article
Characterization of a FOXG1:TLE1 transcriptional network in glioblastoma‐initiating cells.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 6, p. 775, doi. 10.1002/1878-0261.12168
- By:
- Publication type:
- Article
Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22643-w
- By:
- Publication type:
- Article
Hyper-Activation of Notch3 Amplifies the Proliferative Potential of Rhabdomyosarcoma Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0096238
- By:
- Publication type:
- Article
Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-139
- By:
- Publication type:
- Article
Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS.
- Published in:
- 2014
- By:
- Publication type:
- journal article